Ketograce Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a dietary supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analog of essential amino acids, facilitating protein metabolism while minimizing nitrogenous waste production. This mechanism is particularly beneficial in patients with impaired renal function, as it helps reduce the accumulation of uremic toxins and delays the progression of renal insufficiency. Ketograce Tablet is typically prescribed alongside a protein-restricted diet to provide the necessary amino acid precursors without exacerbating azotemia. The use of Alpha Ketoanalogue supports nutritional status by promoting protein synthesis and preventing malnutrition, a common complication in CKD patients. Clinical studies have demonstrated its efficacy in improving metabolic parameters and maintaining muscle mass while reducing serum urea and creatinine levels. Ketograce is indicated for patients with moderate to severe renal impairment and should be used under medical supervision. Dosage adjustments and monitoring of renal function, electrolyte balance, and nutritional status are essential during therapy. Ketograce Tablet is contraindicated in patients with hypersensitivity to its components and should be used cautiously in those with hepatic dysfunction.